Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Month: April 2026

Could an Avocado and Mango a Day Keep High Blood Pressure at Bay?

April 21, 2026 by sugaradmin

Share on PinterestA recent study suggests a daily avocado-mango combo may offer heart health benefits, such as lowering blood pressure. Nadine Greeff/Stocksy Eating one avocado and 1 cup of mango daily may improve blood vessel function in as little as 8 weeks, according to new research. The avocado-mango combo was linked to better flow-mediated dilation […]

Read More
Health NewsLeave a Comment on Could an Avocado and Mango a Day Keep High Blood Pressure at Bay?

Biallelic Pathogenic Variants in IL2RA Cause Neonatal-Onset Monogenic Autoimmune Diabetes

April 21, 2026 by sugaradmin

Autoimmune diabetes presenting in infancy or with additional autoimmune disorders can be the result of highly penetrant variants in key immune homeostasis genes. An example of this is observed with biallelic pathogenic variants in IL2RA (CD25), which causes immunodeficiency 41 (IMD41). IL2RA encodes the α-chain of the interleukin-2 receptor, which helps regulate the growth and […]

Read More
DiabetesLeave a Comment on Biallelic Pathogenic Variants in IL2RA Cause Neonatal-Onset Monogenic Autoimmune Diabetes

Is Your Sleep App Helping or Just Stressing You Out?

April 21, 2026 by sugaradmin

Share on PinterestResearch shows that using sleep apps may increase stress in people with insomnia. Image Credit: janiecbros/Getty Images A recent study has found that the use of sleep apps may lead to negative effects in people with insomnia. The researchers also note that sleep apps may not give an accurate image of your sleep. […]

Read More
Health NewsLeave a Comment on Is Your Sleep App Helping or Just Stressing You Out?

Effects of Pancreatic Resection on Liver Fat Content and Amino Acid, Lipid, and Glucose Metabolism: A Prospective 1-Year Follow-up Study

April 21, 2026 by sugaradmin

Individuals who undergo pancreatic resection are at increased risk of developing hepatic steatosis. Glucagon is a key regulator of hepatic glucose, amino acids, and lipid metabolism, and the change in circulating glucagon is suggested to contribute to the pathogenesis of postoperative steatotic liver disease. Here, we aimed to elucidate hepatic and metabolic changes induced by […]

Read More
DiabetesLeave a Comment on Effects of Pancreatic Resection on Liver Fat Content and Amino Acid, Lipid, and Glucose Metabolism: A Prospective 1-Year Follow-up Study

ANGPTL4 Induces Aberrant Lymphatic-Like Remodeling in Proliferative Diabetic Retinopathy

April 21, 2026 by sugaradmin

Diabetic retinopathy (DR) is a leading cause of vision loss in working-age adults and often progresses to proliferative diabetic retinopathy (PDR) with irreversible complications. Anti–vascular endothelial growth factor (VEGF) therapy remains the first-line treatment; however, resistance poses a significant challenge, necessitating alternative therapeutic targets. This study explores the role of angiopoietin-like protein 4 (ANGPTL4) in […]

Read More
DiabetesLeave a Comment on ANGPTL4 Induces Aberrant Lymphatic-Like Remodeling in Proliferative Diabetic Retinopathy

Normalization of Insulin Resistance Rather Than Hyperglycemia Before Stroke Improves Functional Outcomes in a Mouse Model of Type 2 Diabetes

April 21, 2026 by sugaradmin

Prestroke hyperglycemia and insulin resistance (IR) independently correlate with poor stroke outcomes in type 2 diabetes (T2D), although their causative effect is undetermined. Interestingly, an increasing body of evidence points toward the importance of IR in determining stroke outcomes. Filling this gap is fundamental to identifying effective anti-T2D strategies to improve stroke prognosis in people […]

Read More
DiabetesLeave a Comment on Normalization of Insulin Resistance Rather Than Hyperglycemia Before Stroke Improves Functional Outcomes in a Mouse Model of Type 2 Diabetes

Mesenchymal Stem Cell and Secretome Treatments Inhibit the mTOR–NOX4 Pathway in Diabetic Kidney Disease

April 21, 2026 by sugaradmin

Diabetic kidney disease (DKD) is a major complication of diabetes characterized by progressive renal dysfunction driven by oxidative stress and inflammation involving mammalian target of rapamycin (mTOR) and NADPH oxidase (NOX) pathways. Mesenchymal stem cells (MSCs) have gained attention for their regenerative and immunomodulatory properties in attenuating DKD, but the mechanisms behind their protective effects […]

Read More
DiabetesLeave a Comment on Mesenchymal Stem Cell and Secretome Treatments Inhibit the mTOR–NOX4 Pathway in Diabetic Kidney Disease

Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes

April 21, 2026 by sugaradmin

Noninvasive measurement of pancreatic β-cell mass remains an important unmet need in type 1 diabetes because conventional surrogate markers, such as C-peptide, often lack sensitivity in advanced disease. This study evaluated the glucagon-like peptide 1 receptor–targeted positron emission tomography tracer, 18F-labeled exendin-4–based probe conjugated with polyethylene glycol, [18F]FB(ePEG12)12-exendin-4 (18F-exendin-4), to determine its ability to visualize […]

Read More
DiabetesLeave a Comment on Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes

Metabolite Erythritol in 24-Hour Urine Is Associated With Higher Intrahepatic Lipid Content: The Maastricht Study

April 21, 2026 by sugaradmin

The pentose phosphate pathway (PPP) furnishes NADPH for hepatic de novo lipogenesis, driving intrahepatic lipid (IHL) accumulation. The aim of the current study was to examine the association between the PPP, proxied by 24-h urinary erythritol, and IHL content at the population level. We used cross-sectional data from the Maastricht Study, a population-based cohort study […]

Read More
DiabetesLeave a Comment on Metabolite Erythritol in 24-Hour Urine Is Associated With Higher Intrahepatic Lipid Content: The Maastricht Study

Multiple Mechanisms Contribute to Robust Type 1 Diabetes Protection in Nfkbid – Overexpressing NOD Mice

April 21, 2026 by sugaradmin

We previously reported that transgenic overexpression of Nfkbid in NOD mice led to robust type 1 diabetes protection associated with enhanced negative selection of autoreactive T cells and expansion of regulatory T cells (Tregs) with increased suppressive capacity. The goal of this study was to further identify cellular and molecular mechanisms underlying strong protection from […]

Read More
DiabetesLeave a Comment on Multiple Mechanisms Contribute to Robust Type 1 Diabetes Protection in Nfkbid – Overexpressing NOD Mice

Posts navigation

Older posts
Newer posts

Recent Posts

  • Trump Reclassifies Marijuana as Less Dangerous in Major Policy Shift
  • Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62%
  • FDA Issues Nationwide Recall of ‘Extended Release’ Xanax for Anxiety
  • Viral ‘Egg Coffee’ Drink May Pose Food Safety Risk
  • Can Low Dose Aspirin Lower Your Risk?

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness